nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A5—Dactinomycin—melanoma	0.25	0.43	CbGbCtD
Norepinephrine—CYP1A2—Carmustine—melanoma	0.138	0.238	CbGbCtD
Norepinephrine—CYP1A2—Vemurafenib—melanoma	0.109	0.188	CbGbCtD
Norepinephrine—CYP1A2—Dacarbazine—melanoma	0.0838	0.144	CbGbCtD
Norepinephrine—Isoprenaline—MAPK1—melanoma	0.00319	0.808	CrCbGaD
Norepinephrine—Epinephrine—TNF—melanoma	0.000757	0.192	CrCbGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—melanoma	9.59e-06	2.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—melanoma	9.59e-06	2.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—melanoma	9.56e-06	2.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL8—melanoma	9.55e-06	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—FGF2—melanoma	9.54e-06	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCND1—melanoma	9.52e-06	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CTNNB1—melanoma	9.52e-06	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—melanoma	9.48e-06	2.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CTNNB1—melanoma	9.43e-06	2.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—melanoma	9.4e-06	2.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL8—melanoma	9.39e-06	2.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—melanoma	9.33e-06	2.25e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—melanoma	9.33e-06	2.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1B—melanoma	9.32e-06	2.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAP2K1—melanoma	9.32e-06	2.25e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CTNNB1—melanoma	9.31e-06	2.25e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PIK3CA—melanoma	9.3e-06	2.24e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1A—melanoma	9.3e-06	2.24e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTEN—melanoma	9.27e-06	2.24e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MDM2—melanoma	9.26e-06	2.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CD—melanoma	9.26e-06	2.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—melanoma	9.24e-06	2.23e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NFKB1—melanoma	9.23e-06	2.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—melanoma	9.22e-06	2.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1A—melanoma	9.21e-06	2.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—melanoma	9.19e-06	2.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTEN—melanoma	9.19e-06	2.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1B—melanoma	9.17e-06	2.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	9.17e-06	2.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NFKB1—melanoma	9.15e-06	2.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—melanoma	9.14e-06	2.2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB2—melanoma	9.13e-06	2.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—melanoma	9.13e-06	2.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—melanoma	9.12e-06	2.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—melanoma	9.1e-06	2.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1A—melanoma	9.09e-06	2.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NRAS—melanoma	9.08e-06	2.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—melanoma	9.08e-06	2.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—melanoma	9.08e-06	2.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTEN—melanoma	9.07e-06	2.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—melanoma	9.06e-06	2.19e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—melanoma	9.05e-06	2.18e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NFKB1—melanoma	9.03e-06	2.18e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CB—melanoma	9.01e-06	2.17e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—melanoma	9e-06	2.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—melanoma	8.99e-06	2.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—melanoma	8.98e-06	2.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—melanoma	8.97e-06	2.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	8.96e-06	2.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—melanoma	8.93e-06	2.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MDM2—melanoma	8.93e-06	2.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—melanoma	8.89e-06	2.15e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PRKCA—melanoma	8.88e-06	2.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FGF2—melanoma	8.86e-06	2.14e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—melanoma	8.85e-06	2.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CTNNB1—melanoma	8.81e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ERCC2—melanoma	8.8e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB2—melanoma	8.8e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—melanoma	8.75e-06	2.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK3—melanoma	8.7e-06	2.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CB—melanoma	8.68e-06	2.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CTNNB1—melanoma	8.67e-06	2.09e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—melanoma	8.66e-06	2.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—melanoma	8.63e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—melanoma	8.61e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1A—melanoma	8.6e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTEN—melanoma	8.58e-06	2.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NFKB1—melanoma	8.54e-06	2.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—melanoma	8.5e-06	2.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1A—melanoma	8.47e-06	2.04e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1B—melanoma	8.46e-06	2.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—melanoma	8.46e-06	2.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTEN—melanoma	8.45e-06	2.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NFKB1—melanoma	8.41e-06	2.03e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—melanoma	8.38e-06	2.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—melanoma	8.37e-06	2.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—melanoma	8.37e-06	2.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—melanoma	8.35e-06	2.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTEN—melanoma	8.34e-06	2.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	8.33e-06	2.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—melanoma	8.3e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—melanoma	8.29e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MDM2—melanoma	8.29e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—melanoma	8.29e-06	2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—melanoma	8.29e-06	2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—melanoma	8.28e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK1—melanoma	8.28e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NRAS—melanoma	8.27e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—melanoma	8.27e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—melanoma	8.24e-06	1.99e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—melanoma	8.24e-06	1.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—melanoma	8.22e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NRAS—melanoma	8.2e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—melanoma	8.19e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB2—melanoma	8.18e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	8.15e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—melanoma	8.11e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NRAS—melanoma	8.09e-06	1.95e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—melanoma	8.07e-06	1.95e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	8.07e-06	1.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	8.06e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CTNNB1—melanoma	7.99e-06	1.93e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—melanoma	7.99e-06	1.93e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—melanoma	7.98e-06	1.92e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—melanoma	7.94e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK3—melanoma	7.92e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK3—melanoma	7.85e-06	1.89e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—melanoma	7.83e-06	1.89e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—melanoma	7.82e-06	1.89e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1A—melanoma	7.81e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTEN—melanoma	7.79e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—melanoma	7.77e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—melanoma	7.75e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—melanoma	7.75e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK3—melanoma	7.75e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NFKB1—melanoma	7.75e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—melanoma	7.71e-06	1.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—melanoma	7.7e-06	1.86e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	7.7e-06	1.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—melanoma	7.68e-06	1.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NRAS—melanoma	7.66e-06	1.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—melanoma	7.64e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—melanoma	7.63e-06	1.84e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—melanoma	7.6e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	7.57e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—melanoma	7.56e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—melanoma	7.55e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK1—melanoma	7.54e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—melanoma	7.54e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—melanoma	7.54e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NRAS—melanoma	7.54e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	7.52e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTEN—melanoma	7.5e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	7.49e-06	1.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK1—melanoma	7.47e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—melanoma	7.47e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NFKB1—melanoma	7.47e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CA—melanoma	7.45e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—melanoma	7.42e-06	1.79e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—melanoma	7.41e-06	1.79e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK1—melanoma	7.38e-06	1.78e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—melanoma	7.37e-06	1.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—melanoma	7.37e-06	1.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK3—melanoma	7.33e-06	1.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—melanoma	7.32e-06	1.77e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.29e-06	1.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CA—melanoma	7.24e-06	1.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—melanoma	7.22e-06	1.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK3—melanoma	7.22e-06	1.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	7.18e-06	1.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	7.15e-06	1.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—melanoma	7.13e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—melanoma	7.12e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—melanoma	7.06e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—melanoma	7.03e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—melanoma	7.02e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—melanoma	7.01e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	6.99e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK1—melanoma	6.98e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—melanoma	6.98e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTEN—melanoma	6.97e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—melanoma	6.97e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—melanoma	6.97e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—melanoma	6.95e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NRAS—melanoma	6.95e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—melanoma	6.95e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CA—melanoma	6.94e-06	1.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NFKB1—melanoma	6.94e-06	1.67e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK1—melanoma	6.87e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—melanoma	6.87e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—melanoma	6.8e-06	1.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—melanoma	6.78e-06	1.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—melanoma	6.71e-06	1.62e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARG—melanoma	6.71e-06	1.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NRAS—melanoma	6.69e-06	1.62e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK3—melanoma	6.65e-06	1.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—melanoma	6.64e-06	1.6e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—melanoma	6.59e-06	1.59e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CA—melanoma	6.54e-06	1.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—melanoma	6.49e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	6.48e-06	1.56e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—melanoma	6.47e-06	1.56e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK3—melanoma	6.41e-06	1.55e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CA—melanoma	6.4e-06	1.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—melanoma	6.36e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK1—melanoma	6.33e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—melanoma	6.33e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—melanoma	6.33e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—melanoma	6.3e-06	1.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—melanoma	6.27e-06	1.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—melanoma	6.24e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—melanoma	6.24e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NRAS—melanoma	6.22e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—melanoma	6.19e-06	1.49e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CD—melanoma	6.11e-06	1.47e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK1—melanoma	6.1e-06	1.47e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—melanoma	6.1e-06	1.47e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—melanoma	6.08e-06	1.47e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	6.06e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—melanoma	6.05e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—melanoma	6.03e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—melanoma	6e-06	1.45e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—melanoma	5.98e-06	1.44e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	5.96e-06	1.44e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK3—melanoma	5.96e-06	1.44e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—melanoma	5.92e-06	1.43e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—melanoma	5.92e-06	1.43e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CA—melanoma	5.88e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—melanoma	5.87e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—melanoma	5.86e-06	1.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—melanoma	5.79e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—melanoma	5.79e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—melanoma	5.77e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—melanoma	5.76e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—melanoma	5.74e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—melanoma	5.67e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK1—melanoma	5.67e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—melanoma	5.67e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—melanoma	5.67e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—melanoma	5.6e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—melanoma	5.51e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CA—melanoma	5.49e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—melanoma	5.36e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—melanoma	5.35e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—melanoma	5.34e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CB—melanoma	5.33e-06	1.29e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—melanoma	5.32e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—melanoma	5.3e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	5.29e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—melanoma	5.28e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—melanoma	5.28e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—melanoma	5.23e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—melanoma	5.12e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—melanoma	5.08e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—melanoma	4.95e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	4.92e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—melanoma	4.9e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—melanoma	4.87e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—melanoma	4.87e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—melanoma	4.81e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—melanoma	4.76e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—melanoma	4.69e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTEN—melanoma	4.6e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—melanoma	4.55e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—melanoma	4.49e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—melanoma	4.36e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—melanoma	4.32e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—melanoma	4.02e-06	9.69e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CA—melanoma	3.25e-06	7.83e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—melanoma	2.65e-06	6.4e-06	CbGpPWpGaD
